Literature DB >> 35348986

Chemical biology-based approaches to study adenosine A2A - dopamine D2 receptor heteromers.

Karen J Gregory1, Manuela Jörg2,3.   

Abstract

Entities:  

Year:  2022        PMID： 35348986     DOI： 10.1007/s11302-022-09860-8

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN： 1573-9538            Impact factor:   3.765


× No keyword cloud information.
  19 in total

1.  Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors.

Authors:  Joelle Hillion; Meritxell Canals; Maria Torvinen; Vicent Casado; Rizaldy Scott; Anton Terasmaa; Anita Hansson; Stanley Watson; Mark E Olah; Josefa Mallol; Enric I Canela; Michele Zoli; Luigi F Agnati; Carlos F Ibanez; Carme Lluis; Rafael Franco; Sergi Ferre; Kjell Fuxe
Journal:  J Biol Chem       Date:  2002-02-28       Impact factor: 5.157

Review 2.  Bivalent ligands as specific pharmacological tools for G protein-coupled receptor dimers.

Authors:  Isabelle Berque-Bestel; Frank Lezoualc'h; Ralf Jockers
Journal:  Curr Drug Discov Technol       Date:  2008-12

3.  Synthesis and pharmacological evaluation of dual acting ligands targeting the adenosine A2A and dopamine D2 receptors for the potential treatment of Parkinson's disease.

Authors:  Manuela Jörg; Lauren T May; Frankie S Mak; Kiew Ching K Lee; Neil D Miller; Peter J Scammells; Ben Capuano
Journal:  J Med Chem       Date:  2014-12-24       Impact factor: 7.446

Review 4.  G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.

Authors:  Sergi Ferré; Vicent Casadó; Lakshmi A Devi; Marta Filizola; Ralf Jockers; Martin J Lohse; Graeme Milligan; Jean-Philippe Pin; Xavier Guitart
Journal:  Pharmacol Rev       Date:  2014-02-10       Impact factor: 25.468

Review 5.  The dopamine D2 and adenosine A2A receptors: past, present and future trends for the treatment of Parkinson's disease.

Authors:  M Jorg; P J Scammells; B Capuano
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

6.  Class A G-protein-coupled receptor (GPCR) dimers and bivalent ligands.

Authors:  Christine Hiller; Julia Kühhorn; Peter Gmeiner
Journal:  J Med Chem       Date:  2013-06-04       Impact factor: 7.446

7.  Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers.

Authors:  Aroa Soriano; Ruben Ventura; Anabel Molero; Rob Hoen; Vicent Casadó; Antoni Cortés; Francesca Fanelli; Fernando Albericio; Carmen Lluís; Rafael Franco; Miriam Royo
Journal:  J Med Chem       Date:  2009-09-24       Impact factor: 7.446

8.  Oligomerization of adenosine A2A and dopamine D2 receptors in living cells.

Authors:  Toshio Kamiya; Osamu Saitoh; Kazuaki Yoshioka; Hiroyasu Nakata
Journal:  Biochem Biophys Res Commun       Date:  2003-06-27       Impact factor: 3.575

9.  Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer.

Authors:  Meritxell Canals; Daniel Marcellino; Francesca Fanelli; Francisco Ciruela; Piero de Benedetti; Steven R Goldberg; Kim Neve; Kjell Fuxe; Luigi F Agnati; Amina S Woods; Sergi Ferré; Carme Lluis; Michel Bouvier; Rafael Franco
Journal:  J Biol Chem       Date:  2003-08-21       Impact factor: 5.157

10.  Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia.

Authors:  Marta Valle-León; Luis F Callado; Ester Aso; María M Cajiao-Manrique; Kristoffer Sahlholm; Marc López-Cano; Concepció Soler; Xavier Altafaj; Masahiko Watanabe; Sergi Ferré; Víctor Fernández-Dueñas; José M Menchón; Francisco Ciruela
Journal:  Neuropsychopharmacology       Date:  2020-10-03       Impact factor: 7.853
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.